Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 214.00
+1.80 (0.85%)
At close: Dec 23, 2025
Demant Market Cap
Demant has a market cap or net worth of 45.59 billion as of December 26, 2025. Its market cap has decreased by -23.58% in one year.
Market Cap
45.59B
Enterprise Value
60.70B
Revenue
22.59B
Ranking
n/a
PE Ratio
17.12
Stock Price
214.00
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 45.59B, an increase of 2,051.31%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 45.59B | -20.75% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | 57.66B | 12.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.47T |
| Genmab | 130.78B |
| Coloplast | 122.33B |
| ALK-Abelló | 50.34B |
| H. Lundbeck | 41.13B |
| Zealand Pharma | 33.95B |
| Ambu A/S | 23.39B |
| GN Store Nord | 15.18B |